SUZ12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.047800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.805400E-01
Normal-vs-Stage2
3.325200E-01
Normal-vs-Stage3
2.450600E-01
Normal-vs-Stage4
8.962600E-01
Stage1-vs-Stage2
9.460400E-01
Stage1-vs-Stage3
2.802200E-02
Stage1-vs-Stage4
2.810400E-01
Stage2-vs-Stage3
6.439200E-03
Stage2-vs-Stage4
3.584400E-01
Stage3-vs-Stage4
2.317900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.594030E-01
Normal-vs-AfricanAmerican
6.993600E-01
Normal-vs-Asian
8.777400E-01
Caucasian-vs-AfricanAmerican
2.541000E-01
Caucasian-vs-Asian
6.347800E-01
AfricanAmerican-vs-Asian
9.783000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.445580E-01
Normal-vs-Female
5.040400E-01
Male-vs-Female
1.545570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.730000E-01
Normal-vs-Age(41-60Yrs)
3.796800E-01
Normal-vs-Age(61-80Yrs)
3.196400E-01
Normal-vs-Age(81-100Yrs)
1.608240E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.113710E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.380200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.308600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.278300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.070570E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.144800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.762800E-01
Normal-vs-Daily Drinker
6.028500E-02
Normal-vs-Weekly Drinker
1.780850E-01
Normal-vs-Occasional Drinker
5.441800E-01
Normal-vs-Social Drinker
5.158600E-01
Non Drinker-vs-Daily Drinker
6.929000E-01
Non Drinker-vs-Weekly Drinker
7.932800E-01
Non Drinker-vs-Occasional Drinker
1.788060E-02
Non Drinker-vs-Social Drinker
7.244400E-02
Daily Drinker-vs-Weekly Drinker
6.167000E-01
Daily Drinker-vs-Occasional Drinker
1.572030E-02
Daily Drinker-vs-Social Drinker
4.721700E-02
Weekly Drinker-vs-Occasional Drinker
1.124840E-01
Weekly Drinker-vs-Social Drinker
2.097000E-01
Occasional Drinker-vs-Social Drinker
8.297400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.325980E-01
Normal-vs-Grade 2
1.230980E-01
Normal-vs-Grade 3
3.023500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.089400E-01
Grade 1-vs-Grade 3
5.250000E-01
Grade 1-vs-Grade 4
1.325980E-01
Grade 2-vs-Grade 3
6.306400E-01
Grade 2-vs-Grade 4
1.230980E-01
Grade 3-vs-Grade 4
3.023500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.134360E-01
Normal-vs-NonDiabetic
3.131200E-01
Diabetic-vs-NonDiabetic
3.118200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.181600E-01
Normal-vs-NoPancreatitis
2.956400E-01
Pancreatitis-vs-NoPancreatitis
3.978200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.561400E-01
Normal-vs-N1
3.502000E-01
N0-vs-N1
8.225400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.291800E-01
Normal-vs-TP53-NonMutant
3.668600E-01
TP53-Mutant-vs-TP53-NonMutant
2.848200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
